The Technology Accelerator is the umbrella under which new products or existing products with HIV prevention and multipurpose prevention technology indications can accelerate research and development.
Design to Delivery (D2D) is a working group for engaging stakeholders, including end-users, service providers and other local partners to inform and advance the research and development of innovative emerging HIV prevention options for women.
BACH will help product developers refine their commercialization strategies, develop their business cases, and identify complementary resources to advance products to the finish line.
By strengthening the depth and breadth of existing local partner institutional capacities, CaSE will contribute to creating centers of excellence across Sub-Saharan Africa.
Clinical trials will be designed with optimized strategies to ensure research among African women while providing evidence that informs safety and efficacy of new products supporting expedited approval by stringent regulatory authorities.